DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
O’Connor OA, Wright J, Moskowitz C. et al.
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin’s lymphoma and mantle cell lymphoma.
J Clin Oncol 2005; 23: 676-684
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.